Recent reviews have detailed the role of TGFβ signaling in proliferation, invasion, angiogenesis, immune responses, and therapeutic treatments for malignant gliomas (Han et al., 2015; Birch et al., 2020; Kaminska and Cyranowski, 2020). Here, TGFB1 is linked to malignant glioma.